Antiphospholipid antibodies and thrombosis: assessment of the potential risk for thrombosis

Abstract

Keywords

Lupus anticoagulent protein C activated protein C resistance

Get full access to this article

View all access options for this article.

References

Triplett DA , Antiphospholipid-protein antibodies: laboratory detection and clinical relevance . Thromb Res 1995; 78: 1-31.

McNeil HP , Simpson RJ , Chesterman CN , Krilis SA Antiphospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: β2 Glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 4120-4124.

Bevers EM et al. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only but to a complex of lipid bound prothrombin. Thromb Haemost 1991; 66: 629-632.

Matsuda J. et al. Anti-annexin antibody in the sera of patients with habitual fetal loss or pre-eclampsia. Thromb Res 1994 ; 75: 105-106.

Oosting JD et al. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S. An explanation for their pathogenic mechanism. Blood 1993; 81: 2618-2625.

Sugi T. , McIntyre JA. Auto-antibodies to phosphatidylethanolamine (PE) recognise a kinogen-PE complex. Blood 1995; 86: 3083-3089.

Bowie Ejw , Thompson JH , Pascuzzi CA , Owen CA Thrombosis in systemic lupus erythematosus despite circulating anticoagulants . J Lab Clin Med 1963; 62: 416-430.

Ginsberg KS et al. Anticardiolipin antibodies and the risk for ischaemic stroke and venous thrombosis. Annals of Internal Medicine 1992; 117: 997-1002.

Taylor LM et al. Antiphospholipid antibodies in vascular surgery patients. Ann Surg 1994; 220: 544-551.

10.

Morton KE et al. Coronary artery bypass graft failure - an autoimmune phenomenon ? Lancet 1986; 2: 1353-1357.

11.

Ginsberg JS et al. Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state. Blood 1993; 81: 2958-2963.

12.

Khamashta MA et al. The management of thrombosis in the antiphospholipid antibody syndrome. New Eng J Med 1995; 332(15): 993-997.

13.

Denheizer M. et al. Is hyperhomocystinaemia a risk factor for recurrent venous thrombosis? Lancet 1995 ; 345: 882-885.

14.

Naworth PD , Handley DA , Esmon CT , Slern D. Interleukin I induces endothelial procoagulant while suppressing cell surface anticoagulant activity. Proc Natl Acad Sci USA 1986; 83: 3460.

15.

Comp PC et al. Acquired protein S deficiency occurs in pregnancy, the nephrotic syndrome and systemic lupus erythematosus. Blood 1985; 66: 348.

16.

Dahlback B. Inherited thrombophilia resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood 1995; 85: 607-614.

17.

Esmon CT The regulation of natural anticoagulant pathways. Science 1987; 235: 1348-1352.

18.

Griffin JH et al. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-1373.

19.

Mitchell CA et al. A fatal thrombotic disorder associated with an acquired inhibitor of protein C. New Engl J Med 1987; 317: 1638-1642.

20.

Odegaard B. , Mann KG : Proteolysis of factor Va by factor Xa and activated protein C. J Biol Chem 1987; 262: 11233.

21.

Zoller B. , Dahlback B. : Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1994 ; 343: 1536.

22.

Heeb MJ , Kojima Y. , Greengard JS , Griffin JH Activated protein C resistance molecular mechanisms based on studies using purified (GLN 506) Factor V. Blood 1995 ; 85: 3405-3411.

23.

Hellgren M. , Svenson PJ , Dahlback B. : Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives . Am J Obstet Gyn 1995; 173: 210-213.

24.

Ridker PM et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. New Engl J Med 1995; 332: 912-917.